Characterisation of biological pathways dysregulated in amyotrophic lateral sclerosis (ALS) cases with a hexanucleotide repeat expansion of C9ORF72.

Research Categorization
Researcher and Organization
Principal Investigator
Principal Investigator First Name
J
Principal Investigator Last Name
Cooper-Knock
Awardee Organization
Contact PI Country
Project Detail
FY Overall Cost
$192,130
Funding Organization
Funding Organization Country